38266062|t|Comprehensive analysis of clinical and biological features in Parkinson's disease associated with the LRRK2 G2019S mutation: Data from the PPMI study.
38266062|a|The Parkinson's Progression Marker Initiative (PPMI) aims to identify biomarkers for Parkinson's disease (PD) risk, onset, and progression. This study focuses on the G2019S missense mutation in the LRRK2 gene, which is associated with hereditary and sporadic PD. Utilizing data from the PPMI database, we conducted an analysis of baseline clinical characteristics, as well as serum and cerebrospinal fluid levels in two groups: patients with PD with the G2019S mutation (PD + G2019S) and patients with PD without the mutation (PD-G2019S). Multiple linear regression and longitudinal analysis were performed, controlling for confounding factors. Compared to the PD-G2019S group, the PD + G2019S group showed more obvious initial motor dysfunction-higher baseline Movement Disorder Society-Sponsored Revision of the Unified Parkinson Disease Rating Scale (MDS-UPDRS) scores (false discovery rate [FDR]-adjusted p < 0.001), but progressed more slowly. Mechanism of Coordinated Access and activities of daily living (ADL) scores were lower at baseline (FDR-adjusted p < 0.001), whereas Scales for Outcomes of Parkinson's Disease (SCOPA)-Thermoregulatory (FDR-adjusted p = 0.015) scores were higher, emphasizing the increase of non-motor symptoms associated with LRRK2-G2019S mutation. During the follow-up period, the motor and non-motor symptoms changed dynamically with time, and there were longitudinal differences in the scores of MDS-UPDRS (FDR-adjusted PI  = 0.013, PII  = 0.008, PIV  < 0.001), Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (FDR-adjusted p = 0.027), SCOPA-Thermoregulatory (FDR-adjusted p = 0.021), and ADL (FDR-adjusted p = 0.027) scale scores. PD associated with the LRRK2 G2019S mutation demonstrated more severe symptoms at baseline but slower progression. Motor complications and thermoregulatory disorders were more pronounced.
38266062	62	81	Parkinson's disease	Disease	MESH:D010300
38266062	102	107	LRRK2	Gene	120892
38266062	108	114	G2019S	ProteinMutation	tmVar:p|SUB|G|2019|S;HGVS:p.G2019S;VariantGroup:0;CorrespondingGene:120892;RS#:34637584;CorrespondingSpecies:9606;CA#:339926
38266062	155	166	Parkinson's	Disease	MESH:D010300
38266062	236	255	Parkinson's disease	Disease	MESH:D010300
38266062	257	259	PD	Disease	MESH:D010300
38266062	317	323	G2019S	ProteinMutation	tmVar:p|SUB|G|2019|S;HGVS:p.G2019S;VariantGroup:0;CorrespondingGene:120892;RS#:34637584;CorrespondingSpecies:9606;CA#:339926
38266062	349	354	LRRK2	Gene	120892
38266062	410	412	PD	Disease	MESH:D010300
38266062	579	587	patients	Species	9606
38266062	593	595	PD	Disease	MESH:D010300
38266062	605	611	G2019S	ProteinMutation	tmVar:p|SUB|G|2019|S;HGVS:p.G2019S;VariantGroup:0;CorrespondingGene:120892;RS#:34637584;CorrespondingSpecies:9606;CA#:339926
38266062	622	624	PD	Disease	MESH:D010300
38266062	627	633	G2019S	ProteinMutation	tmVar:p|SUB|G|2019|S;HGVS:p.G2019S;VariantGroup:0;CorrespondingGene:120892;RS#:34637584;CorrespondingSpecies:9606;CA#:339926
38266062	639	647	patients	Species	9606
38266062	653	655	PD	Disease	MESH:D010300
38266062	678	680	PD	Disease	MESH:D010300
38266062	681	687	G2019S	ProteinMutation	tmVar:p|SUB|G|2019|S;HGVS:p.G2019S;VariantGroup:0;CorrespondingGene:120892;RS#:34637584;CorrespondingSpecies:9606;CA#:339926
38266062	812	814	PD	Disease	MESH:D010300
38266062	815	821	G2019S	ProteinMutation	tmVar:p|SUB|G|2019|S;HGVS:p.G2019S;VariantGroup:0;CorrespondingGene:120892;RS#:34637584;CorrespondingSpecies:9606;CA#:339926
38266062	833	835	PD	Disease	MESH:D010300
38266062	838	844	G2019S	ProteinMutation	tmVar:p|SUB|G|2019|S;HGVS:p.G2019S;VariantGroup:0;CorrespondingGene:120892;RS#:34637584;CorrespondingSpecies:9606;CA#:339926
38266062	879	896	motor dysfunction	Disease	MESH:D000068079
38266062	913	930	Movement Disorder	Disease	MESH:D009069
38266062	973	990	Parkinson Disease	Disease	MESH:D010300
38266062	1256	1275	Parkinson's Disease	Disease	MESH:D010300
38266062	1409	1414	LRRK2	Gene	120892
38266062	1415	1421	G2019S	ProteinMutation	tmVar:p|SUB|G|2019|S;HGVS:p.G2019S;VariantGroup:0;CorrespondingGene:120892;RS#:34637584;CorrespondingSpecies:9606;CA#:339926
38266062	1666	1696	Impulsive-Compulsive Disorders	Disease	MESH:D003193
38266062	1700	1719	Parkinson's Disease	Disease	MESH:D010300
38266062	1842	1844	PD	Disease	MESH:D010300
38266062	1865	1870	LRRK2	Gene	120892
38266062	1871	1877	G2019S	ProteinMutation	tmVar:p|SUB|G|2019|S;HGVS:p.G2019S;VariantGroup:0;CorrespondingGene:120892;RS#:34637584;CorrespondingSpecies:9606;CA#:339926
38266062	1981	2007	thermoregulatory disorders	Disease	MESH:D009358
38266062	Association	MESH:D003193	RS#:34637584;HGVS:p.G2019S;CorrespondingGene:120892
38266062	Association	MESH:D000068079	RS#:34637584;HGVS:p.G2019S;CorrespondingGene:120892
38266062	Association	MESH:D009358	RS#:34637584;HGVS:p.G2019S;CorrespondingGene:120892
38266062	Association	MESH:D009069	RS#:34637584;HGVS:p.G2019S;CorrespondingGene:120892
38266062	Association	MESH:D010300	RS#:34637584;HGVS:p.G2019S;CorrespondingGene:120892
38266062	Association	MESH:D003193	120892
38266062	Association	MESH:D009358	120892
38266062	Association	MESH:D010300	120892
38266062	Association	MESH:D000068079	120892
38266062	Association	MESH:D009069	120892

